Skip to main navigation Skip to search Skip to main content

MTG-022: Translational Medicine: Discovery and Evaluation of Biomarkers/Pharmacogenomics for the Diagnosis and Personalized Management of Patients

Project: Research

Project Details

StatusActive
Effective start/end date10/9/25 → 06/21/26

Funding

  • MT Group Incorporated: $6,720.00